Adjuvant Intra-arterial Injection of Iodine-131-Labeled Lipiodol after Resection of Hepatocellular Carcinoma

Hepatology

Volumn 38, Issue 5, 2003, Pages 1237-1241

  Boucher, Eveline ^a   Corbinais, Stéphane ^a   Rolland, Yan ^a   Bourguet, Patrick ^a   Guyader, Dominique ^b   Boudjema, Karim ^b   Meunier, Bernard ^b   Raoul, Jean Luc ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL I 131; IODINE 131;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0142182774     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50473     Document Type: Article

References (17)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353: 1253-1257.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334: 693-699.
3. Llovet J, Fuster J, Bruix J, BCLC Group. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. HEPATOLOGY 1999;30:1434-1440.
4. Castellano L, Calandra M, Del Vecchio Blanco C, de Sio I. Predictive factors of survival and intra-hepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol 1997;27:862-870.
5. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomized controlled trial comparing percutaneous acid acetic injection and ethanol injection for small hepatocellular carcinoma. HEPATOLOGY 1998;27:67-72.
6. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
7. Bowles BJ, Machi J, Limm WM, Severino R, Oishi AJ, Furumoto NL, Wong LL, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-869.
8. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999;353:797-801.
9. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra arterial iodine-131-iodized oil versus chemoembolisation. J Nucl Med 1994;35:1782-1787.
10. Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, Bekhechi D, et al. Prospective randomized trial of chemoembolisation versus intra arterial injection of 131-I-labelled-iodized oil in the treatment of hepatocellular carcinoma. HEPATOLOGY 1997;26: 1156-1161.
11. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-928.
12. Prospective validation of CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The cancer of the liver Italian program investigators. HEPATOLOGY 2000;31:840-845.
13. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients. Meta analysis of three randomised controlled trials. Cancer 2001;91:2378-2385.
14. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet 2002;3:593-603.
15. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1999;334:1561-1567.
16. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, Varotti G, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003;237:536-543.
17. Tan CK, Law NM, Ng HS, Machin D. Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. J Clin Oncol 2003;21:2294-2298.